Free Trial

Divisadero Street Capital Management LP Makes New Investment in ZimVie Inc. (NASDAQ:ZIMV)

ZimVie logo with Medical background

Divisadero Street Capital Management LP bought a new stake in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 29,969 shares of the company's stock, valued at approximately $418,000. Divisadero Street Capital Management LP owned 0.11% of ZimVie as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. SG Americas Securities LLC raised its position in ZimVie by 15.7% during the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock valued at $155,000 after buying an additional 1,508 shares during the period. EMC Capital Management increased its holdings in shares of ZimVie by 47.0% in the 4th quarter. EMC Capital Management now owns 13,802 shares of the company's stock valued at $193,000 after purchasing an additional 4,414 shares during the period. Wells Fargo & Company MN lifted its position in shares of ZimVie by 17.8% in the fourth quarter. Wells Fargo & Company MN now owns 17,037 shares of the company's stock worth $238,000 after purchasing an additional 2,569 shares in the last quarter. Integrated Quantitative Investments LLC purchased a new position in ZimVie during the fourth quarter valued at approximately $248,000. Finally, Principal Financial Group Inc. grew its position in ZimVie by 9.8% during the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company's stock valued at $266,000 after purchasing an additional 1,702 shares in the last quarter. Hedge funds and other institutional investors own 95.63% of the company's stock.

ZimVie Stock Down 4.7 %

NASDAQ ZIMV traded down $0.43 during trading on Friday, reaching $8.76. The company's stock had a trading volume of 249,399 shares, compared to its average volume of 215,098. The business has a 50-day moving average price of $10.32 and a 200-day moving average price of $12.64. ZimVie Inc. has a 1-year low of $8.56 and a 1-year high of $22.40. The stock has a market capitalization of $243.94 million, a PE ratio of -0.67 and a beta of 2.16. The company has a current ratio of 1.94, a quick ratio of 1.38 and a debt-to-equity ratio of 0.57.

ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $0.27 earnings per share (EPS) for the quarter. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The firm had revenue of $112.00 million during the quarter, compared to analysts' expectations of $113.10 million. On average, research analysts forecast that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ZIMV. Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th. B. Riley initiated coverage on ZimVie in a research report on Thursday, April 10th. They set a "buy" rating and a $16.00 price objective for the company.

Read Our Latest Stock Report on ZimVie

ZimVie Profile

(Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Recommended Stories

Institutional Ownership by Quarter for ZimVie (NASDAQ:ZIMV)

Should You Invest $1,000 in ZimVie Right Now?

Before you consider ZimVie, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.

While ZimVie currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines